Delta-Fly Pharma,Inc. (4598.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

Market Cap

JPY 1.34B

MomentumView details →

1D Return

−9.02%

YTD Return

−76.27%

RSI (14)

53.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

Market Cap

JPY 1.34B

RSI (14)

53.9

MomentumView details →

1D Return

−9.02%

YTD Return

−76.27%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−802.90%

ROA (TTM)

−509.82%

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

+26.68%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+1.61%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

2.41x

Quick Ratio

2.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

−1.66B

Op. CF (TTM)

—

Next earningsNov 16, 2026 →

Latest newsMore news →

On September 1, 2026, four stocks hit limit-up and four hit limit-down at the close on the Tokyo Stock Exchange, including Brain's Technology, DeltaFly Pharma, Asterisk, and others.4d ago

Delta-Fly Pharma reported progress in the phase 2/3 trial of DFP-17729 for advanced pancreatic cancer, with favorable survival rates.5d ago

Similar companies

FunPep Company Limited4881.T Perseus Proteomics Inc.4882.T CHUKYO IYAKUHIN CO.,LTD.4558.T Veritas In Silico Inc.130A.T Kringle Pharma,Inc.4884.T SymBio Pharmaceuticals Limited4582.T Find similar companies →

Latest newsMore news →

On September 1, 2026, four stocks hit limit-up and four hit limit-down at the close on the Tokyo Stock Exchange, including Brain's Technology, DeltaFly Pharma, Asterisk, and others.4d ago Delta-Fly Pharma reported progress in the phase 2/3 trial of DFP-17729 for advanced pancreatic cancer, with favorable survival rates.5d ago